Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Extension of EUR-1008 (Zenpep) in Infants with EPI due to CF
NCT01131507Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- Jul 2010
- Primary completion
- Dec 2011
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pancreatin in exocrine pancreatic insufficiency (EPI), sponsored by Forest Laboratories. Started Jul 2010; status: completed.
02
Drugs
pancreatin
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT01131507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01131507.